Home » Topics » BioWorld Science

BioWorld Science
RSS

NBTXR3 improves survival in preclinical model of anti-PD-1-resistant lung cancer

Jan. 28, 2022

PDS-0202 universal flu vaccine neutralizes multiple strains of influenza in preclinical studies

Jan. 28, 2022

Cereno advances CS-014 for cardiovascular diseases

Jan. 28, 2022

Chinese researchers discover new SST2 receptor ligands

Jan. 28, 2022

Bacainn Therapeutics synthesizes new NLRP inflammasome inhibitors

Jan. 28, 2022

Gilgamesh Pharmaceuticals identifies new 5-HT2A receptor agonists

Jan. 28, 2022

BridGene Biosciences divulges YAP1/TEAD interaction inhibitors

Jan. 28, 2022

Pfizer patents new JAK inhibitors

Jan. 28, 2022

Beta-elemene NO derivatives demonstrate potent antiglioma activity in vivo

Jan. 28, 2022

Novel nonviral engineered BAFF-CAR T cells show efficacy in multiple B-cell cancer models

Jan. 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...